Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Authors
Hunter-Lavin, ClaireDavies, Emma L.
Bacelar, Maria M. F. V. G.
Marshall, Michael J.
Andrew, Sarah M.
Williams, John H. H.
Affiliation
University of Chester ; University of Chester ; University of Chester ; The Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry ; University College Chester ; University College ChesterPublication Date
2004-11-12
Metadata
Show full item recordAbstract
There are an increasing number of studies reporting the presence of Hsps in human serum. We have investigated the release of Hsp70 into blood and culture medium from peripheral blood mononuclear cells (PBMCs), and whether this release is due to cell damage or active secretion from the cells. Intact Hsp70 was released from cells within whole blood and from purified PBMCs under normal culture conditions. Hsp70 release was rapid (0.1 ng/106 cells/h) over the first 2 h of culture and continued at a reduced rate up to 24 h (<0.025 ng/106 cells/h). Using viable cell counts and lactate dehydrogenase release we were able to confirm that the release of Hsp70 was not due to cellular damage. Hsp70 release was inhibited by monensin, methyl-β-cyclodextrin, and methylamine, but not by brefeldin A. These data suggest that Hsp70 is released from cells via a non-classical pathway, possibly involving lysosomal lipid rafts.Citation
Biochemical and Biophysical Research Communications, 324(2), 2004, pp. 511-517Publisher
ElsevierAdditional Links
http://www.elsevier.com/wps/find/journaldescription.cws_home/622790/description#descriptionType
ArticleLanguage
enDescription
This article is not available through ChesterRep.ISSN
0006-291X1090-2104
Sponsors
This article was submitted to the RAE2008 for the University of Chester - Allied Health Professions and Studies.ae974a485f413a2113503eed53cd6c53
10.1016/j.bbrc.2004.09.075